# Mirati Therapeutics Inc Mirati Therapeutics Inc COM

Mirati Therapeutics Inc Mirati Therapeutics Inc COM is a security (CUSIP 60468T105) tracked across SEC portfolio filings. 3 registered fund positions totaling $26.5M via N-PORT as of 2021-02-28.

## Summary

- Issuer: Mirati Therapeutics Inc
- Class: Mirati Therapeutics Inc COM
- CUSIP: 60468T105
- Asset category: EC
- 13F holders: 0
- N-PORT fund positions: 3
- N-PORT value: $26.5M
- N-PORT report: 2021-02-28

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [Touchstone Institutional Funds Trust-Touchstone Sands Capital Institutional Growth Fund](https://search.stillhousedata.com/fund/S000001455) | Touchstone Institutional Funds Trust | $22.7M | 97.86% |
| [UBS U.S. EQUITY ALPHA RELATIONSHIP FUND](https://search.stillhousedata.com/fund/S000003186) | UBS RELATIONSHIP FUNDS | $2.1M | 69.30% |
| [Small Cap Growth Fund](https://search.stillhousedata.com/fund/S000008021) | VALIC Co II | $1.6M | 53.66% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/60468T105.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.